Last updated: April 4, 2024
Sponsor: Hôpital Privé de la Baie
Overall Status: Active - Recruiting
Phase
N/A
Condition
Glaucoma
Treatment
Minimally invasive microsclerostomy
Clinical Study ID
NCT06213805
2023-A02193-42
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients ≥ 18 years old who agree to participate in the study having signed informedconsent
- Primary open-angle glaucoma, pseudoexfoliative glaucoma or pigmentary glaucoma withindication for glaucoma surgery (defined as uncontrolled intraocular pressure orworsening of visual fields, despite maximum tolerated medical therapy) and openiridocorneal angle ( trabecular meshwork visible on gonioscopy, Shaffer classificationgrade 3-4) and healthy and mobile conjunctiva (without scars or adhesions).
- Chronic angle closure glaucoma with indication for combined glaucoma and cataractsurgery
Exclusion
Exclusion Criteria:
- Presence of other ophthalmological pathologies (except cataract)
- History of intraocular surgery (unless cataract surgery), history of trauma, orconjunctival scarring in the quadrant planned for surgery
- Visual acuity lower than "counts fingers" ", closure of the iridocorneal angle (andangle-closure glaucoma unless associated cataract surgery), neovascular glaucoma orneovascularization of the iris, pachymetry < 490 μm or > 620 μm.
- Presence of severe systemic pathologies, pregnant or breastfeeding woman
Study Design
Total Participants: 23
Treatment Group(s): 1
Primary Treatment: Minimally invasive microsclerostomy
Phase:
Study Start date:
January 15, 2024
Estimated Completion Date:
February 28, 2026
Connect with a study center
Hôpital Privé de la Baie
Avranches, 50300
FranceActive - Recruiting
Clinique Thiers
Bordeaux, 33100
FranceSite Not Available
Fondation Rothschild
Paris, 75019
FranceSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.